SI-BONE Inc. (SIBN), a medical device company dedicated to addressing musculoskeletal disorders of the sacropelvic anatomy, has begun the year on a high note, showcasing robust performance in the first quarter of 2024.
The flagship product of the company is iFuse Implant System, a minimally invasive surgical treatment for sacroiliac joint disorders. The sacroiliac joint is the joint connection between the lower spine and the pelvis. Dysfunction in the sacroiliac joint is thought to cause low back pain and/or leg pain.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.